These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16275614)

  • 1. The immunopharmacological properties of transforming growth factor beta.
    Le Y; Yu X; Ruan L; Wang O; Qi D; Zhu J; Lu X; Kong Y; Cai K; Pang S; Shi X; Wang JM
    Int Immunopharmacol; 2005 Dec; 5(13-14):1771-82. PubMed ID: 16275614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta (TGF-beta) and autoimmunity.
    Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-betas and vascular disorders.
    Bobik A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1712-20. PubMed ID: 16675726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta (transforming growth factor-beta) in chronic inflammatory conditions - a new diagnostic and prognostic marker?
    Marek A; Brodzicki J; Liberek A; Korzon M
    Med Sci Monit; 2002 Jul; 8(7):RA145-51. PubMed ID: 12118214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta and the immune response to malignant disease.
    Teicher BA
    Clin Cancer Res; 2007 Nov; 13(21):6247-51. PubMed ID: 17975134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New regulatory mechanisms of TGF-beta receptor function.
    Kang JS; Liu C; Derynck R
    Trends Cell Biol; 2009 Aug; 19(8):385-94. PubMed ID: 19648010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TGF-beta in allergic inflammation.
    Schmidt-Weber CB; Blaser K
    Immunol Allergy Clin North Am; 2006 May; 26(2):233-44, vi-vii. PubMed ID: 16701142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe?
    Salib RJ; Howarth PH
    Clin Exp Allergy; 2009 Aug; 39(8):1128-35. PubMed ID: 19400903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
    Liu X; Sun SQ; Hassid A; Ostrom RS
    Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current review on the role of transforming growth factor beta (TGF-beta) in some pathological disorders].
    Krzemień S; Knapczyk P
    Wiad Lek; 2005; 58(9-10):536-9. PubMed ID: 16529065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble transforming growth factor-beta receptor: advantages and applications.
    Russo LM; Brown D; Lin HY
    Int J Biochem Cell Biol; 2009 Mar; 41(3):472-6. PubMed ID: 18339576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
    Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of transforming growth factor-beta in atherosclerosis.
    Singh NN; Ramji DP
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):487-99. PubMed ID: 17056295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.